About this trial
This study seeks to explore the various methods used by transgender men for sexual intercourse following phalloplasty or metoidioplasty, focusing on their satisfaction with different erectile aids, as well as the satisfaction of their partners. Phalloplasty and metoidioplasty are gender-affirming surgeries that often require additional aids to achieve the desired sexual function, particularly for penetration. While internal erectile prostheses are common after phalloplasty, they come with high complication rates, leading some patients to opt for non-surgical aids. However, the effectiveness and comfort of these aids are not well-documented. This study aims to fill this gap by examining the types of aids transgender men use, how well these aids meet their sexual needs, and how satisfied both they and their partners are with the outcomes, providing much-needed insight for healthcare providers and patients alike.
Eligibility criteria
Qualifiers
Patient and partner age ≥ 18 years.
Transgender or gender non-conforming individuals (and their partners).
Patients have undergone phalloplasty or metoidioplasty as a form of genital gender affirming surgery.
≥6 months after phalloplasty or metoidioplasty (any type of flap or technique is allowed).
Disqualifiers
Patient age < 18 years.
Cisgender patients treated with phalloplasty or metoidioplasty for various reasons.
<6 months after phalloplasty or metoidioplasty.
Not sexually active since phalloplasty/metoidioplasty.
Trial design
Treatments tested in this trial
- Questionnaire